Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

UNLABELLED: Bisphosphonates (BPs) are well established as the leading drugs for the treatment of osteoporosis. There is new knowledge about how they work. The differences that exist among individual BPs in terms of mineral binding and biochemical actions may explain differences in their clinical be...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Russell, R, Watts, N, Ebetino, F, Rogers, M
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

Bisphosphonates: Mechanisms of Action
di: Roelofs, A, et al.
Pubblicazione: (2008)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
di: Russell, R, et al.
Pubblicazione: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
di: Russell, R, et al.
Pubblicazione: (2007)

Molecular modeling of the bisphosphonates in farnesyl diphosphate synthase. potential new details of the precise biochemical mechanism of action of potent nitrogen containing bisphosphonates
di: Ebetino, F, et al.
Pubblicazione: (2002)

Denosumab and bisphosphonates: different mechanisms of action and effects.
di: Baron, R, et al.
Pubblicazione: (2011)

Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
di: Nancollas, G, et al.
Pubblicazione: (2006)

Bisphosphonates--mechanisms of action in multiple myeloma.
di: Shipman, C, et al.
Pubblicazione: (2000)

A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonates in clinical use
di: Ebetino, E, et al.
Pubblicazione: (2005)

The pharmacology of bisphosphonates and new insights into their mechanisms of action.
di: Russell, R, et al.
Pubblicazione: (1999)

Mineral binding affinities and zeta potentials of bisphosphonates
di: Nancollas, G, et al.
Pubblicazione: (2002)

Investigations into the kinetic mechanism of inhibition of farnesyl diphosphate synthase by nitrogen containing bisphosphonates
di: Dunford, J, et al.
Pubblicazione: (2006)

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
di: Kavanagh, K, et al.
Pubblicazione: (2006)

Molecular modeling of the bisphosphonates (BPs) in farnesyl diphosphate (FPP) synthase. Proposed new mechanism of inhibition by potent nitrogen containing bisphosphonates (NBPs).
di: Ebetino, F, et al.
Pubblicazione: (2002)

Analysis of the kinetic mechanism of inhibition of Farnesyl Pyrophosphate Synthase by nitrogen containing bisphosphonates.
di: Dunford, J, et al.
Pubblicazione: (2006)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
di: Ebetino, F, et al.
Pubblicazione: (2006)

A computational model explains bisphosphonate binding affinity differences on hydroxyapatite
di: Ebetino, F, et al.
Pubblicazione: (2006)

Bisphosphonates: mode of action and pharmacology.
di: Russell, R
Pubblicazione: (2007)

Differences between bisphosphonates in binding affinities for hydroxyapatite.
di: Lawson, M, et al.
Pubblicazione: (2010)

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo.
di: Roelofs, A, et al.
Pubblicazione: (2012)

Potential bone mineral binding differences among bisphosphonates can be demonstrated by the use of hydroxyapatite column chromatography.
di: Lawson, M, et al.
Pubblicazione: (2005)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
di: Pazianas, M, et al.
Pubblicazione: (2010)

Bisphosphonate bone affinity, differences predicted by in vitro binding to carbonated apatite
di: Henneman, Z, et al.
Pubblicazione: (2004)

Bisphosphonate bone affinity, differences predicted by in vitro carbonated apatite model.
di: Henneman, Z, et al.
Pubblicazione: (2003)

Differentiation of bisphosphonates based on their physical chemical properties
di: Phipps, R, et al.
Pubblicazione: (2006)

Mineral binding affinities of bisphosphonates.
di: Nancollas, G, et al.
Pubblicazione: (2002)

Modeling of bisphosphonate binding to farnesyl diphosphate synthase
di: Ebetino, F, et al.
Pubblicazione: (2002)

Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates
di: Dunford, J, et al.
Pubblicazione: (2007)

Physiological and biological mechanisms of bisphosphonate action
di: Duan, X
Pubblicazione: (2011)

Refining the use of hydroxyapatite column chromatography to reveal differences in relative binding affinities of bisphosphonates
di: Lawson, M, et al.
Pubblicazione: (2006)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
di: Mabilleau, G, et al.
Pubblicazione: (2010)

BONE AFFINITY DIFFERENCES OF NITROGEN-CONTAINING BISPHOSPHONATES PREDICTED BY IN VITRO BINDING TO CARBONATED APATITE
di: Ebetino, F, et al.
Pubblicazione: (2004)

Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo
di: Roelofs, A, et al.
Pubblicazione: (2009)

New developments in bisphosphonate research. Improving our understanding of their differences mechanistically.
di: Ebetino, F, et al.
Pubblicazione: (2002)

Predicting the clinical potencies of bisphosphonates: Divergence of hydroxyapatite and farnesyl diphosphate synthase binding affinities
di: Xia, Z, et al.
Pubblicazione: (2007)

Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase
di: Ebetino, F, et al.
Pubblicazione: (2005)

The use of hydroxyapatite column chromatography as a novel method to reveal differences in relative binding affinities of bisphosphonates
di: Lawson, M, et al.
Pubblicazione: (2005)

Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.
di: Henneman, Z, et al.
Pubblicazione: (2008)

Bisphosphonate affinity to hydroxyapatite and farnesyl pyrophosphate inhibitory potency, together, drive in vivo efficacy
di: Lundy, M, et al.
Pubblicazione: (2007)

Comparative mineral binding affinities of selected bisphosphonates
di: Nancollas, G, et al.
Pubblicazione: (2002)

Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
di: Dunford, J, et al.
Pubblicazione: (2008)